Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
651
DELISTED
Acceleron Pharma
XLRN
| $69.6M | 0.02% |
554,274
+566
| +0.1% | +$71.4K |
|
652
Ares Capital
ARCC
$14.3B
| $69.5M | 0.02% |
3,545,371
+163,970
| +5% | +$3.18M |
|
653
Cardlytics
CDLX
$22.4M
| $69.2M | 0.02% |
54,590
-1,126
| -2% | -$1.27M |
|
|
BCPC
654
Balchem Corp
BCPC
$5.65B
| $69.2M | 0.02% |
526,832
+1,230
| +0.2% | +$158K |
|
655
iShares ESG Aware MSCI EM ETF
ESGE
$6.69B
| $69M | 0.02% |
1,530,825
+126,251
| +9% | +$5.59M |
|
656
KKR & Co
KKR
$93.2B
| $68.8M | 0.02% |
1,162,005
-121,641
| -9% | -$6.75M |
|
657
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $68.4M | 0.02% |
1,112,747
-87,777
| -7% | -$5.4M |
|
658
Avient
AVNT
$4.19B
| $68.4M | 0.02% |
1,390,520
-9,170
| -0.7% | -$464K |
|
659
Ameris Bancorp
ABCB
$5.88B
| $68.3M | 0.02% |
1,349,265
+2,358
| +0.2% | +$127K |
|
660
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
| $67.9M | 0.02% |
1,128,606
+55,940
| +5% | +$3.34M |
|
661
Kraft Heinz
KHC
$29.6B
| $67.8M | 0.02% |
1,663,741
-603,076
| -27% | -$25.4M |
|
662
Atkore
ATKR
$3.17B
| $67.8M | 0.02% |
954,623
-215,631
| -18% | -$16.4M |
|
|
MRTX
663
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $67.4M | 0.02% |
417,352
+114,710
| +38% | +$18.4M |
|
664
Lennox International
LII
$14.6B
| $67.1M | 0.02% |
191,339
-2,443
| -1% | -$824K |
|
665
iShares Select Dividend ETF
DVY
$23.6B
| $66.9M | 0.02% |
574,309
+44,898
| +8% | +$5.34M |
|
666
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
| $66.9M | 0.02% |
985,762
-222,884
| -18% | -$12.3M |
|
667
Graco
GGG
$13.5B
| $66.8M | 0.02% |
883,494
-1,770
| -0.2% | -$133K |
|
668
iShares Floating Rate Bond ETF
FLOT
$10.5B
| $66.6M | 0.02% |
1,295,840
+352,299
| +37% | +$17.9M |
|
|
COUP
669
DELISTED
Coupa Software Incorporated
COUP
| $66.3M | 0.02% |
252,966
+21,361
| +9% | +$5.29M |
|
670
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
| $66M | 0.02% |
2,088,964
+446,912
| +27% | +$14.6M |
|
671
Lithia Motors
LAD
$8.35B
| $65.9M | 0.02% |
191,900
-11,057
| -5% | -$4M |
|
672
Edison International
EIX
$26.1B
| $65.9M | 0.02% |
1,139,401
+10,938
| +1% | +$636K |
|
673
Penumbra
PEN
$12.8B
| $65.9M | 0.02% |
240,416
-103,127
| -30% | -$28.1M |
|
674
CACI
CACI
$14.3B
| $65.9M | 0.02% |
258,127
+10,280
| +4% | +$2.65M |
|
675
Biogen
BIIB
$30.6B
| $65.6M | 0.02% |
189,409
-8,513
| -4% | -$2.58M |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.